HELPER CONSTRUCTS FOR PRODUCING HYBRID rAAV PARTICLES OF VARIOUS AAV SEROTYPES

Details for Australian Patent Application No. 2003214104 (hide)

Owner MEDIGENE AG

Inventors KOSFELD-BERGAUER, Meike; HORER, Markus; DUBIELZIG, Ralf; RIES, Stefan

Pub. Number AU-A-2003214104

PCT Number PCT/EP03/02351

PCT Pub. Number WO2003/074686

Priority 102 10 139.6 07.03.02 DE

Filing date 7 March 2003

Wipo publication date 16 September 2003

International Classifications

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 015/86 Mutation or genetic engineering - Viral vectors

C12N 015/00 Mutation or genetic engineering

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 102 10 139.6 07.03.02 DE

23 October 2003 Application Open to Public Inspection

  Published as AU-A-2003214104

25 November 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003214105-Use of enzyme inhibitors with aminopeptidase N and/or dipeptidylpeptidase IV activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases with seborrhoeic hyperproliferation and altered differentiation states

2003214103-METHOD FOR IDENTIFYING SPECIFIC RNA-INHIBITORS